RYTHMOL

This brand name is authorized in Canada, France, United States, South Africa

Active ingredients

The drug RYTHMOL contains one active pharmaceutical ingredient (API):

1 Propafenone UNII 33XCH0HOCD - PROPAFENONE HYDROCHLORIDE

Propafenone is a class IC anti-arrhythmic agent. It has a stabilising action on myocardial membranes, reduces the fast inward current carried by sodium ions with a reduction in depolarisation rate and prolongs the impulse conduction time in the atrium, AV node and primarily, in the His-Purkinje system. Read about Propafenone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RYTHMOL SR Capsule	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C01BC03	Propafenone	C Cardiovascular system → C01 Cardiac therapy → C01B Antiarrhythmics, class I and III → C01BC Antiarrhythmics, class Ic
Discover more medicines within C01BC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00603708, 00603716
Country: FR	Base de données publique des médicaments	Identifier(s): 66843923
Country: US	FDA, National Drug Code	Identifier(s): 0173-0823, 0173-0824, 0173-0826
Country: ZA	Health Products Regulatory Authority	Identifier(s): R/6.2/149, R/6.2/150